Vijaya Ramesh

Also affiliated with Neurology, Inc

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling”.

TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling

Molecular Autism(2020)10.1186/s13229-019-0311-3

N/A

0.590DataRank · unranked

50 citations

Vilas Wagh, Surya A. Reis, Serkan Erdin, Roberta L. Beauchamp, Ghalib Shaikh +6 more

Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations

Molecular Autism(2023)10.1186/s13229-023-00572-3

N/A

0.406DataRank · unranked

14 citations

Pauline Martín, Françis Robert, Krzysztof J. Szkop, Nicholas E. Redmond, Srirupa Bhattacharyya +8 more

Multi-center, single arm phase II study of the dual mTORC1/mTORC2 inhibitor vistusertib for patients with recurrent or progressive grade II-III meningiomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2024

N/A

0.345DataRank · unranked

9 citations

Priya Kumthekar, Patrick Y. Wen, Frederick G. Barker, Anat Stemmer‐Rachamimov, Roberta L. Beauchamp +4 more

Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae024

N/A

0.241DataRank · unranked

4 citations

Janet L. Oblinger, Roberta L. Beauchamp, Lili Kosa, Françis Robert, Scott R. Plotkin +3 more

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition

Journal of Biological Chemistry(2020)10.1074/jbc.ra120.014960

N/A

0DataRank · unranked

18 citations

Serkan Erdin, Luke Witt, Justin T. Jordan, Scott R. Plotkin, James F. Gusella +2 more

Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin

Science Advances(2021)10.1126/sciadv.abb1703

N/A

0DataRank · unranked

39 citations

Shilpa Prabhakar, David Yellen, Roberta L. Beauchamp, Xuan Zhang, Shingo Kasamatsu +12 more

Translatome analysis of Tuberous Sclerosis Complex-1 patient-derived neural progenitor cells reveal rapamycin-dependent and independent alterations

Research Square(2023)10.21203/rs.3.rs-2702044/v1

N/A

0DataRank · unranked

0 citations

Pauline Martín, Françis Robert, Krzysztof J. Szkop, Nicholas E. Redmond, Shan Chen +6 more

Evolving concepts in meningioma management in the era of genomics

Cancer(2024)10.1002/cncr.35279

N/A

0DataRank · unranked

12 citations

Wenya Linda Bi, Vijaya Ramesh, Priscilla K. Brastianos, Scott R. Plotkin, Annie L. Hsieh

Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma

Neuro-Oncology(2023)10.1093/neuonc/noad037

N/A

0DataRank · unranked

10 citations

Janet L. Oblinger, Roberta L. Beauchamp, Zhenzhen Yin, Serkan Erdin, Priya Koundinya +8 more

SMARCE1 deficiency generates a targetable mSWI/SNF dependency in clear cell meningioma

Nature Genetics(2022)10.1038/s41588-022-01077-0

N/A

0DataRank · unranked

43 citations

Clayton K. Collings, Daniel D. Samé Guerra, Christian J. Widmer, Olubusayo Bolonduro, Nazar Mashtalir +10 more